What are the responsibilities and job description for the Associate Director, Alliance Management position at Genesis Therapeutics?
The Associate Director, Alliance Management is a high-impact role that will help oversee critical and strategic collaborations at Genesis, including existing alliances with major pharmaceutical companies, with a particular focus on AI-focused platform partnerships. This role will also support new and existing technology collaborations related to the GEMS platform, and may provide support to various other strategic initiatives.
This role will report to the Vice President, Business Development and may be based at Genesis Therapeutics' physical offices in Burlingame CA or San Diego (hybrid schedule).
What You Will Do (Key Responsibilities)
- Alliance management
- Act as alliance manager for Genesis's AI-focused research collaborations with major pharmaceutical companies
- Own communication with key external stakeholders, support Genesis project teams, and drive preparations for all joint research governance meetings
- Technology collaborations
- Act as business lead on critical technology and AI infrastructure deals to support GEMS platform capabilities and leading computational research at Genesis
- Examples include major cloud computing contracts, GPU infrastructure for AI model scaling, data generation and other complementary technologies
- Strategic initiatives
- Support Genesis corporate communications and media strategy, interfacing directly with Genesis's external communications agency
- Provide strategic perspectives on GEMS platform roadmap based on insights from partnerships with major pharmaceutical and technology companies
What You'll Bring
We'd Be Thrilled If You Have Experience With
What We Offer
Genesis Therapeutics is unifying AI and biotech to discover novel and breakthrough treatments for patients with severe and devastating conditions. Genesis was founded on groundbreaking molecular ML research and since has established itself as the industry leader in AI for small molecule drug discovery. Our team of accomplished biotech leaders and expert drug hunters joins forces with deep learning researchers and software engineers who are pioneering predictive and generative AI technologies for molecules.
Our team has created the industry's most advanced molecular AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery and to enable the discovery of novel first-in-class and best-in-class small molecule drugs for challenging and / or undruggable targets.
The company has leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has signed AI-focused platform collaborations with major pharmaceutical companies, including most recently Incyte Corporation (Feb 2025) and Gilead Sciences (Sept 2024).
We raised a $200M series B in August 2023, and have raised over $300M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures.
Genesis is headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.
J-18808-Ljbffr
